211 related articles for article (PubMed ID: 27860083)
1. Dermoscopic monitoring of efficacy of ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas.
Diluvio L; Bavetta M; Di Prete M; Orlandi A; Bianchi L; Campione E
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27860083
[TBL] [Abstract][Full Text] [Related]
2. Ingenol mebutate for pigmented superficial basal cell carcinomas: evaluation by confocal microscopy.
Monfrecola G; Scalvenzi M; Costa C; Cantelli M; Fabbrocini G
G Ital Dermatol Venereol; 2019 Oct; 154(5):586-588. PubMed ID: 27284778
[TBL] [Abstract][Full Text] [Related]
3. Ingenol mebutate: an introduction.
Fallen RS; Gooderham M
Skin Therapy Lett; 2012 Feb; 17(2):1-3. PubMed ID: 22358305
[TBL] [Abstract][Full Text] [Related]
4. Successfully treated superficial basal cell carcinomas with ingenol mebutate 0.05% gel: Report of twenty cases.
Izzi S; Sorgi P; Piemonte P; Carbone A; Frascione P
Dermatol Ther; 2016 Nov; 29(6):470-472. PubMed ID: 27550505
[TBL] [Abstract][Full Text] [Related]
5. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.
Diluvio L; Campione E; Paternò EJ; Orlandi A; Terrinoni A; Chimenti S
J Dermatolog Treat; 2009; 20(2):124-9. PubMed ID: 18991155
[TBL] [Abstract][Full Text] [Related]
6. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis.
Carbotti M; Coppola R; Zanframundo S; Devirgiliis V; Panasiti V
Biomed Res Int; 2018; 2018():4381019. PubMed ID: 30246021
[TBL] [Abstract][Full Text] [Related]
8. PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.
Siller G; Rosen R; Freeman M; Welburn P; Katsamas J; Ogbourne SM
Australas J Dermatol; 2010 May; 51(2):99-105. PubMed ID: 20546215
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the inflammatory response triggered by topical ingenol mebutate 0.05% gel in basal cell carcinoma.
García-de-la-Fuente MR; Santacana M; Verdaguer J; Vilardell F; Garí E; Casanova JM
Australas J Dermatol; 2020 May; 61(2):e200-e207. PubMed ID: 31944277
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution.
Diluvio L; Lanna C; Lozzi F; Palumbo V; Bianchi L; Campione E
Dermatol Ther; 2019 May; 32(3):e12908. PubMed ID: 30968527
[TBL] [Abstract][Full Text] [Related]
12. Effect of ingenol mebutate on actinic keratosis in a Korean population: A prospective clinical, dermoscopic and histopathological study from a single center.
Kim JS; Woo YR; Kim M; Park HJ
J Dermatol; 2018 Nov; 45(11):1324-1330. PubMed ID: 30260493
[TBL] [Abstract][Full Text] [Related]
13. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
Erlendsson AM
Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic options for actinic keratosis and basal cell carcinoma.
Sligh JE
Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S76-80. PubMed ID: 25268601
[TBL] [Abstract][Full Text] [Related]
15. Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study.
Bobyr I; Campanati A; Consales V; Martina E; Molinelli E; Diotallevi F; Brisigotti V; Giangiacomi M; Ganzetti G; Giuliodori K; Offidani A
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):260-266. PubMed ID: 27453064
[TBL] [Abstract][Full Text] [Related]
16. Superficial basal cell carcinoma successfully treated with ingenol mebutate gel 0.05%.
Cantisani C; Paolino G; Cantoresi F; Faina V; Richetta AG; Calvieri S
Dermatol Ther; 2014; 27(6):352-4. PubMed ID: 25052730
[No Abstract] [Full Text] [Related]
17. Fast evaluation and monitoring of ingenol mebutate treatment of multiple basal cell carcinomas by in vivo hand-held reflectance confocal microscopy.
Manubens E; Barreiro A; Bennassar A; Podlipnik S; Moreno N; Iglesias P; Malvehy J; Puig S
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e284-e286. PubMed ID: 27859830
[No Abstract] [Full Text] [Related]
18. Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis.
Pizzichetta MA; Kittler H; Stanganelli I; Bono R; Cavicchini S; De Giorgi V; Ghigliotti G; Quaglino P; Rubegni P; Argenziano G; Talamini R;
Br J Dermatol; 2015 Jul; 173(1):106-14. PubMed ID: 25916655
[TBL] [Abstract][Full Text] [Related]
19. Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response.
Pampena R; Benati E; Borsari S; Bombonato C; Lombardi M; Raucci M; Mirra M; Lallas A; Apalla Z; Papadimitriou I; Moscarella E; Kyrgidis A; Argenziano G; Pellacani G; Longo C
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1461-1468. PubMed ID: 29356164
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
